RCKT
ROCKET PHARMACEUTICALS, INC.
ROCKET PHARMACEUTICALS, INC. (RCKT) has 8 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 6, 2026.
Insiders have net sold $240K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Gaurav D. Shah
- Employees:202
- HQ:Cranbury, NJ, US
- IPO:2015-02-18
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$240K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$372.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Shah GauravFirst filing | CEO | Sale | 55,684 | $172K | May 26 | SEC ↗ |
Chaudhuri SarbaniFirst filing | See Remarks | Sale | 17,650 | $68K | May 11 | SEC ↗ |
Related companies
ROCKET PHARMACEUTICALS, INC. is in the Healthcare sector.